REACH MD | Certain diabetes drugs may be linked to increased risk of Inflammatory Bowel Disease (IBD)

News

A Canadian team, led by Laurent Azoulay at McGill University, set out to assess whether the use of DPP-4 inhibitors is associated with inflammatory bowel disease in patients with type 2 diabetes.
Reach MD

Tags: